By performing a similar analysis on apoptosis-resistant persister CLL cells in patients undergoing treatment with VEN (4) (Supplemental Table 3), we noted that these cells were similarly impaired in Bax activation upon incubation with VEN, S63845, or A1155463 in an ATA ex vivo (Figure 1D). Here, BAX is linked to B-cell chronic lymphocytic leukemia.